Table 1.
Association between the expression of LMTK3 and clinicopathological characteristics.
| Variable | Total patients | LKTK3 expression | ||
|---|---|---|---|---|
| Low | High | P | ||
| Age, mean ± SD (years) | 59.5 ± 11.2 | 58.9 ± 10.2 | 59.7 ± 9.5 | 0.738 |
| Age, n (%) | 0.649 | |||
| <65 years | 28 (41.2) | 18 (64.3) | 10 (35.7) | |
| ≥65 years | 40 (58.8) | 29 (72.5) | 11 (27.5) | |
| Sex, n (%) | 0.969 | |||
| Male | 47 (69.1) | 22 (46.8) | 25 (53.2) | |
| Female | 21 (30.9) | 9 (42.9) | 12 (57.1) | |
| Stage, n (%) | <0.001 | |||
| II | 24 (11.0) | 19 (79.2) | 5 (20.8) | |
| III | 38 (23.0) | 13 (34.2) | 25 (65.8) | |
| IV | 6 (15.3) | 1 (16.7) | 5 (83.3) | |
| Grade, n (%) | 0.039 | |||
| Low | 23 (33.8) | 15 (65.2) | 8 (34.8) | |
| High | 45 (66.2) | 16 (35.6) | 29 (64.4) | |